Coronavirus: Adar Poonawalla Says Serum Institute Will Give First 50 Million Doses Of Covishield To India New Delhi: Stating that the delay in approval of the COVID-19 Oxford-AstraZeneca vaccine, produced en masse by his company, was not concerning, Adar Poonawalla from the Serum Institute of India (SII) said the inoculant …
Read More »
The first indigenous pneumonia vaccine, developed by the Serum Institute of India (SII), was launched by the Union’s health minister, Harsh Vardhan, on Monday. The vaccine will be sold under the name ‘Pneumosil’ and will be available as a single dose in a vial and pre-filled syringe or as a …
Read More »
This new variant is concerning because it is more transmissible and has mutated more than the new variant that has been discovered in the UK, authorities said. In the UK, two cases of another new South African-related coronavirus have been identified, Health Secretary Matt Hancock revealed in London on Wednesday. …
Read More »
A Maharashtra civil court has issued a notice to the Serum Institute of India (SII) in a bogus lawsuit that seeks to prevent the pharmaceutical company from using the trademark “COVISHIELD” or “COVID-SHIELD” or any other identical or similar name for its proposed vaccine for the Coronavirus-induced pandemic. The civil …
Read More »
NEW DELHI: Serum Institute of India (SII) may gain emergency use approval for Covishield in India shortly after UK drug regulator MHRA gives the go-ahead to the vaccine, which officials here hope will be before Christmas. The Medicines and Healthcare Products Regulatory Agency (MHRA) is evaluating data including which dosage …
Read More »
BENGALURU: The Serum Institute of India, the world’s largest producer of vaccines by volume, is close to signing a supply contract with the country’s central government and is likely to set prices at 250 rupees ($ 3.39) per dose of the vaccine, Business Standard reported Tuesday: citing people familiar with …
Read More »
A senior Health Ministry official told The Hindu that Covishield is logistically more feasible for use and distribution in India, as it stores well between two and eight degrees Celsius. The Serum Institute of India (SII) said on Monday that it had applied to the Controller General of Drugs of …
Read More »
The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the country citing needs. not covered due to the pandemic and in interest. from …
Read More »
However, distributing the vaccines in India’s first mass vaccination campaign for adults could be a daunting task. It will require expanding India’s existing cold chain capacity at breakneck speed, especially in some of the most densely populated parts of the country, where such infrastructure is very limited. It will also …
Read More »
Even as Covid-19 cases continue to decline across the country, the Center is busy mapping out a roadmap to ensure last-mile vaccine delivery to all citizens of the country. The prime minister held a meeting with Gennova Biopharma, Biological E and Dr. Reddy’s on Monday. These three pharmaceutical companies are …
Read More »